potential indications for glp-1 receptor agonists keep expanding Use of and GIP/GLP-1 Respiratory Disorders: Where Are We at? GLP-1 for Diabetes vs GLP-1

The additives commonly included in compounded formulations, such as B12 , glycine , or L-carnitine , are vitamins and amino acid derivatives that are not controlled substances and will not produce positive drug test results

J Am Coll Cardiol (2020) 75(16):195674

Unless Medicaid covers obesity medications, enrollees are unlikely to have access to them given the high out-of-pocket cost even at lower prices

While exposure to long-term therapy is of potential concern, it is uncertain whether drug exposure to GLP-1 receptor agonist therapies for shorter durations is of any clinical consequence 28

88.9%), and therapeutic inertia was observed in only 45 individuals (11.1%) (Table 6)

These factors are reflected in the joint ADAEASD guidelines, which place a focus on putting the patient at the center of the treatment paradigm and consider that shared decision-making between patient and provider is essential to create an effective management plan [68]